Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/392,317external-prioritypatent/US5795966A/en
Application filed by Immunex CorpfiledCriticalImmunex Corp
Publication of NZ334128ApublicationCriticalpatent/NZ334128A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
This use of antagonists of mammalian interleukin-15 ("IL-15") that prevent IL-15 from effecting signal transduction through either the â- or ã-subunits of the IL-15 receptor complex, is in medicaments for treating various disease states including treating allograft rejection and graft-versus-host disease.
NZ334128A1995-02-221999-02-10Methods of treatment for patients have GVHD (graft versus host disease) with an antagonists of IL-15 (Interleukin-15)
NZ334128A
(en)
Gas-containing microparticles, agents containing them, their use in medical diagnosis by ultrasonic techniques and methods of producing said particles and agents.